Loren Data's SAM Daily™

SAMDAILY.US - ISSUE OF APRIL 29, 2023 SAM #7823
SPECIAL NOTICE

V -- Transportation and Transit Services

Notice Date

4/27/2023 9:29:55 AM
 

Notice Type

Special Notice
 

NAICS

561990 — All Other Support Services
 

Contracting Office

FDA OFFICE OF OPERATIONS Silver Spring MD 20993 USA
 

ZIP Code

20993
 

Solicitation Number

75F40123R00071
 

Response Due

5/19/2023 9:00:00 AM
 

Point of Contact

Natapol Sirikhan, Phone: 240-402-8031
 

E-Mail Address

Natapol.Sirikhan@fda.hhs.gov
(Natapol.Sirikhan@fda.hhs.gov)
 

Small Business Set-Aside

8AN 8(a) Sole Source (FAR 19.8)
 

Description

Notice of Intent Sole Source This announcement is not a Request for Proposal. The US Food and Drug Administration {FDA), Office of Finance Budget Acquisition and Planning, intends to award a sole source award,� in accordance with Section 8(a) of the Small Business Act (15 U.S.C. � 637(a)), and the Federal Acquisition Regulation (FAR) Part 19.8, and the executed Partnership Agreement between the U.S. Small Business Administration (SBA) and the U.S. Food and Drug Administration; under an 8(a) BUSINESS DEVELOPMENT (BD) PROGRAM - SOLE SOURCE REQUIREMENT UNDER THE EXECUTED PARTNERSHIP AGREEMENT PROGRAM -� SBA Requirement #BD1676407151H; to�a current contract holder, C2 ALASKA, LLC. The requirement is to provide transportation, transit and parking related services for the Food and Drug Administration (FDA). Services will primarily be provided on the White Oak Campus (WO), located at 20903 New Hampshire Ave, Silver Spring, Maryland 10993, and at other agency sites in the Washington, DC-Metropolitan Area. The propose simplified acquisition is for services; the Government intends to solicit and negotiate to only one source. A determination by the Government not to compete this proposed simplified acquisition based upon responses to this notice, is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive requirement. No further solicitation is available. FDA will consider all responses received prior to the closing date of this notice and will use responses in determining, whether it is necessary to use full and open competition for this requirement. Responses shall be emailed to Natapol Sirikhan, Natapol.Sirikhan@fda.hhs.gov, by 05/19/23, 12:00 PM EST.
 

Web Link

SAM.gov Permalink
(https://sam.gov/opp/de7ee66fce314dab900562cb53fd303d/view)
 

Place of Performance

Address: Silver Spring, MD 20993, USA

Zip Code: 20993

Country: USA
 

Record

SN06664254-F 20230429/230427230105 (samdaily.us)
 

Source

SAM.gov Link to This Notice
(may not be valid after Archive Date)

---

| FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |